ISW Holdings Triples Active Cryptocurrency Mining Fleet with Additional POD5IVE Datacenters

LAS VEGAS, March 02, 2021 (GLOBE NEWSWIRE) — via InvestorWire — ISW Holdings, Inc. (OTC: ISWH) (“ISW Holdings” or the “Company”), a diversified portfolio comprised of essential business lines that serve consumer product demands in decentralized markets, is pleased to announce that, following the signing of hosting agreements with Bit5ive LLC, based in Miami, Florida, and Scrubgrass Generating Company, LLP, based in Kennerdell, Pennsylvania, the Company has successfully tripled its active cryptocurrency mining fleet with the addition of two (2) new POD5IVE datacenters.

The Company now operates a total of three POD5IVE datacenter units and anticipates record acceleration in cash flows, revenue growth and profitability.

The POD5IVE datacenter, produced in partnership with Bit5ive, is based on an evolutionary design. Specifications include:

  • Active Mining Power: 62-92 Th/s depending on the miners.
  • SHA 256 Hashrate: Currently 6,557.28 TH/s.
  • Per POD5IVE quantity: 3x 280-360.
  • Depending on each miner, 1x 280 and type of miner: 3x Up S17/T17, 1x up to S19/T19.
  • Power capacity: Each POD5IVE can go 2x 800A, 2x 1000A or 2x 1200A.
  • Total power capacity per POD5IVE: 4x 920,038.40 Watts (current site is using 800A fuse per service).
  • Container Size: 40′ x 8′.
  • Shelving: 3x with 10 medium Racks, 1x with 4 large racks.
  • Voltage: 415V 3 Phase.
  • Ventilation: Passive airflow with a temperature-controlled evaporative cooler (133,000 CFM total each).
  • Digital smart breakers, virtual power monitoring, auto rebooting and wattage protection.
  • Door lock system (automated, warm air recirculation): Basic locks with keys.
  • Purchase price per POD: $168,000.
  • Manufacturing & delivery: 10-12 weeks.
  • Master Capacity: 280 for S19/T19.

Alonzo Pierce, president and chairman of ISW Holdings, commented, “We have now tripled our mining activity with the addition of two new POD5IVE mining pods. The Company will continue to significantly add to our fleet over the coming quarters. We are also building a valuable track record with our mining pods, which will validate the strong value presented when we enter our next phase and begin marketing the Proceso POD5IVE Datacenter as a self-contained, high-efficiency, low-maintenance cryptocurrency mining equipment solution.”

About ISW Holdings
ISW Holdings, Inc., through its in-house operations and strategic partnerships, has invested in growing operations targeting the home healthcare, telehealth, cryptocurrency mining and supply chain management industries. The Company’s expertise lies in strategic brand development, early growth facilitation, as well as brand identity through a proprietary procurement process. Management maneuvers its proprietary companies through critical stages of market development, which include conceptualization, go-to-market strategies, engineering, product integration and distribution efficiency.

For more information, visit www.iswholdings.com.

Forward-Looking Statements
This press release may contain forward-looking statements that involve risks and uncertainties. These statements relate to future events or our future financial performance. In some cases, you can identify forward-looking statements by terminology including “could,” “may,” “will,” “should,” “expect,” “plan,” “anticipate,” “believe,” “estimate,” “predict,” “potential” and the negative of these terms or other comparable terminology. While these forward-looking statements, and any assumptions upon which they are based, are made in good faith and reflect our current judgment regarding the direction of our business, actual results will almost always vary, sometimes materially, from any estimates, predictions, projections, assumptions or other future performance suggested in this report. Except as required by applicable law, we do not intend to update any of the forward-looking statements so as to conform these statements to actual results. Investors should refer to the risks disclosed in the Company’s reports filed from time to time with OTC Markets (www.otcmarkets.com).

Wire Service Contact

InvestorWire (IW)
Los Angeles, California
www.InvestorWire.com
212.418.1217 Office
Editor@InvestorWire.com

TigerGraph Raises $105 Million to Accelerate Graph Analytics on the Cloud

Record Funding for Graph Database Category, Led by Tiger Global, Signals the Next Wave in Analytics to Fuel Powerful Insights for Artificial Intelligence

REDWOOD CITY, Calif., Feb. 17, 2021 (GLOBE NEWSWIRE) — TigerGraph, provider of the leading graph analytics platform, today announced it has raised $105 million in Series C funding, the largest funding round to date within the graph database and analytics market. The round was led by Tiger Global and brings TigerGraph’s total funding raised to over $170 million.

The investment reflects TigerGraph’s growth and the massive potential as businesses continue to move to the cloud. With the transactional and analytical workloads moving to the cloud made possible by companies like Snowflake, Confluent, and Databricks, TigerGraph is quickly becoming the graph database of choice to connect, analyze and learn new insights from the data. With its distributed native graph architecture, TigerGraph helps organizations scale fast and analyze many different aspects of data to be used with each other to form new models and generate new insights. These new patterns and insights enhance a company’s analytics or machine learning capabilities and can be deployed anywhere with multi-cloud flexibility and support the data security requirements for regulatory compliance.

Over the last 12 months with the COVID-19 pandemic, companies have embraced digital transformation at a faster pace, driving an urgent need to find new insights about their customers, products, services, and suppliers. Graph technology connects these domains from the relational databases, offering the opportunity to shrink development cycles for data preparation, improve data quality, and identify new insights such as similarity patterns to deliver the next best action recommendation. Data-driven solutions require intelligent apps and connected data that leverage powerful graph engines to connect, analyze and learn from the data companies are storing in the cloud. These events helped TigerGraph experience massive growth, more than doubling revenues and customers over the past year. It has also continued building a very active and fast-growing developer community, receiving the highest marks in a recent analyst report — TigerGraph was named a leader for Graph Data Platforms in the analyst report.

“By 2023, graph technologies will facilitate rapid contextualization for decision making in 30 percent of organizations worldwide,” according to Gartner.1 Mark Beyer, Distinguished VP Analyst with Gartner, shared the following in a Gartner report regarding the adoption of graph technology in the enterprises, “To Graph or Not to Graph? That Is Not the Question — You Will Graph.”2 Organizations of all sizes are adopting graph-based analytics and AI by leveraging the relationships in the connected data to drive better outcomes. TigerGraph is galvanizing the graph and AI community, organizing the first open industry Graph + AI Conference featuring presentations by innovators including UnitedHealth Group, Jaguar Land Rover, Intuit, Intel, Xilinx and Accenture. TigerGraph is deeply involved and on the steering committee for the development of the Graph Query Language standard, GQL, along with other database vendors such as Oracle and Neo4j, and will enthusiastically support the GQL standard immediately upon finalization.

“For over 40 years, businesses’ #1 data management challenge has been how to easily ask business questions across all of their data in real-time to guide their operations. The human brain connects data to derive new insights and helps us decide what to do next. TigerGraph’s mission is to power an enterprise brain with graph and AI that discovers these new insights within the enterprise data stored in the cloud and on-prem,” said Dr. Yu Xu, founder and CEO of TigerGraph. “TigerGraph is leading the paradigm shift in connecting and analyzing data via scalable and native graph technology with pre-connected entities versus the traditional way of joining large tables with rows and columns. This funding will allow us to expand our offering and bring it to many more markets, enabling more customers to realize the benefits of graph analytics and AI.”

TigerGraph’s innovation has been recognized with several recent industry awards and accolades including:

The company will use the funding for product innovation and development to better support its customers, including TigerGraph Cloud on Google Cloud Platform (available March 2021), plus further multi-region support on AWS and Azure. It is also expanding its global reach with local support in Asia and Australia/New Zealand. Meanwhile, the company will scale up with additional hiring in the Americas, EMEA, and APAC to meet increased product demand. The company is hiring in every department – apply now at https://www.tigergraph.com/join-us/.

Helpful Links
● Get TigerGraph
● TigerGraph Cloud
● TigerGraph Website
● TigerGraph Blog
● TigerGraph on Twitter
● TigerGraph on LinkedIn

Gartner Press Release, Gartner Identifies Top 10 Data and Analytics Technology Trends for 202022 June 2020
2 Gartner, Graph Steps Onto the Main Stage of Data and Analytics: A Gartner Trend Insight Report, 14, December 2020

About TigerGraph
TigerGraph is a platform for advanced analytics and machine learning on connected data. Based on the industry’s first and only distributed native graph database, TigerGraph’s proven technology supports advanced analytics and machine learning applications such as fraud detection, anti-money laundering (AML), entity resolution, customer 360, recommendations, knowledge graph, cybersecurity, supply chain, IoT, and network analysis. The company is headquartered in Redwood City, California, USA. Start free with tigergraph.com/cloud.

Media Contact
Cathy Wright
Offleash PR for TigerGraph
cathy@offleashpr.com
650-678-1905

Lithium Werks Elects Jack Perkowski to Board of Directors as a Non-Executive Director

AUSTIN, Texas and ENSCHEDE, The Netherlands, Feb. 16, 2021 (GLOBE NEWSWIRE) — Lithium Werks BV is proud to announce the election of Jack Perkowski as a non-executive director to the Lithium Werks Board of Directors. Perkowski joins founders T. Joseph Fisher, III and Christian R. Ringvold as directors of the company.

Perkowski brings a wealth of experience and knowledge in fields of corporate strategy, raising capital and assembling management teams.

Perkowski founded ASIMCO Technologies in 1994, and from 1994 to 2008, served as the Chairman of ASIMCO’s Board of Directors and the company’s Chief Executive Officer. Under Perkowski’s leadership, ASIMCO became one of the most important players in China’s automotive components industry and gained a reputation for developing local management and integrating a broad-based China operation into the global economy.

In 2009, Perkowski founded JFP Holdings, a merchant banking firm focused on China, where he now serves as Chairman. JFP Holdings was established to help integrate the world’s greatest providers of technology and know-how with China’s rapidly growing economy by helping foreign companies gain access to the China market and helping domestic companies develop global footprints.

Perkowski currently also serves on the China Advisory Council of Magna International Inc., one of the world’s largest auto suppliers; the Board of Advisers for the Center for Emerging Markets at Northeastern University; the International Advisory Board of Management and Economics (IABME) at Tianjin University in China; and as a member of the Board of Directors for ADOMANI, Inc., a publicly traded electric vehicle company.

Widely recognized as an expert on doing business in China, Perkowski authored Managing the Dragon: How I’m Building a Billion Dollar Business in China. Perkowski is a frequent speaker and commentator on the subject of China to the broadcast media.

“We are thrilled to welcome Jack to our Board. His international contacts and global business acumen will be of great benefit to Lithium Werks as we continue to grow and expand our international presence,” commented T. Joseph Fisher, III, who is co-founder and Chief Executive Officer.

Lithium Werks possesses the world’s most comprehensive portfolio of Lithium Iron Phosphate materials, cells, intellectual property LFP patents and products.  Lithium Werks operates in China, Europe, and the United States. For more information, please visit us at www.lithiumwerks.com.

Contact:
lwmarketing@lithiumwerks.com

LeddarTech Partners With Seoul Robotics to Deliver Robust Solid-State LiDAR-Based Perception Solutions

QUEBEC CITY and SEOUL, Korea, Feb. 16, 2021 (GLOBE NEWSWIRE) — LeddarTech®, an industry leader in environmental sensing solutions for autonomous vehicles and advanced driver assistance systems from Level 1 to Level 5, is proud to announce that Seoul Robotics, the leading 3D computer vision company using AI and machine learning to power the future of mobility, has joined the Leddar™ Ecosystem. The Leddar Ecosystem comprises leading technology companies that have partnered with LeddarTech through the contribution of their expertise in various technologies that enhance ADAS and AD solutions.

Seoul Robotics, headquartered in Seoul, South Korea, has demonstrated expertise in LiDAR perception technology utilizing its proprietary SENSR 3D software. This platform analyzes and processes LiDAR data with high accuracy, enabling more industries, including retail, logistics, and smart cities, to apply 3D insights. Seoul Robotics has garnered much attention in recent years, with the company earning the “No. 1 Tech Startup” spot for South Korea by DB-Stars in 2019.

LeddarTech and Seoul Robotics are collaborating to develop real-time advanced perception solutions to complement LeddarTech’s Leddar™ Pixell, designed for shuttles, robotaxis, ADVs, buses, and heavy commercial vehicles. The Leddar Pixell, a 3D flash solid-state 180-degree sensor, is considered the most robust LiDAR available. The product recently received the Outstanding & Innovative Product Award by the Shenzhen Automotive Electronics Industry Association and Best of Innovation Award Honoree recognition at CES 2020. The partnership of LeddarTech and Seoul Robotics harnesses the technical expertise of both to provide customers with an enhanced LiDAR-based solution that will increase performance and robustness while shortening time-to-market and reducing costs.

“Robust LiDAR sensors like the Leddar Pixell require the most advanced 3D perception software to process and interpret data in real time,” shared Mr. HanBin Lee, co-founder and CEO of Seoul Robotics. “Our industry-leading perception platform, SENSR, enables stronger understanding and interpretation of 3D data, better serving the market with highly detailed, LiDAR-based perception. Through our collaboration in the Leddar Ecosystem, we will provide object detection and classification, as well as speed measurement, direction, and location information without a need for map data, all while reducing cost and increasing efficiency.”

“By partnering with Seoul Robotics, a respected leader in 3D perception software for LiDAR sensors, LeddarTech and our customers benefit from Seoul Robotics’ advanced and innovative LiDAR-based perception technology,” said Charles Boulanger, CEO of LeddarTech. “The collaboration yields a solution to greatly ease and accelerate the integration of the Leddar Pixell in a wide range of applications in mobility and industrial markets,” concluded Mr. Boulanger.

About Seoul Robotics

Seoul Robotics is a 3D computer vision company building a perception platform that uses AI and machine learning to power the future of mobility. Founded in 2017, Seoul Robotics has partnered with OEMs, system integrators, and government agencies around the world to diversify the use of 3D data. The company has developed its own proprietary software, which is compatible with nearly all LiDAR and 3D data sensors, to increase accuracy and efficiency and to ensure safety across a range of industries and applications. Seoul Robotics has offices in Seoul, Silicon Valley, Munich, and Detroit and is backed by leading global financial institutions. For more information, visit www.seoulrobotics.org.

Contact: LaunchSquad for Seoul Robotics at seoulrobotics@launchsquad.com.

About LeddarTech

LeddarTech is a leader in environmental sensing platforms for autonomous vehicles and advanced driver assistance systems. Founded in 2007, LeddarTech has evolved to become a comprehensive end-to-end environmental sensing company by enabling customers to solve critical sensing and perception challenges across the entire value chain of the automotive and mobility market segments. With its LeddarVision™ sensor-fusion and perception platform and its cost-effective, scalable, and versatile LiDAR development solution for automotive-grade solid-state LiDARs based on the LeddarEngine™, LeddarTech enables Tier 1-2 automotive system integrators to develop full-stack sensing solutions for autonomy level 1 to 5. These solutions are actively deployed in autonomous shuttles, trucks, buses, delivery vehicles, smart cities/factories, and robotaxi applications. The company is responsible for several innovations in cutting-edge automotive and mobility remote-sensing applications, with over 95 patented technologies (granted or pending) enhancing ADAS and autonomous driving capabilities.

Additional information about LeddarTech is accessible at www.leddartech.com and on LinkedIn, Twitter, Facebook, and YouTube.

Contact:
Daniel Aitken, Vice-President, Global Marketing, Communications, and Product Management, LeddarTech Inc.
Tel.: + 1-418-653-9000 ext. 232
daniel.aitken@leddartech.com

Leddar, LeddarTech, LeddarEngine, LeddarVision, LeddarSP, LeddarCore, VAYADrive, VayaVision, and related logos are trademarks or registered trademarks of LeddarTech Inc. and its subsidiaries. All other brands, product names, and marks are or may be trademarks or registered trademarks used to identify products or services of their respective owners.

Centrient Pharmaceuticals to acquire Astral SteriTech, expanding its product portfolio with sterile injectable antibiotic finished dosage forms

Rotterdam, the Netherlands, February 15th, 2021, Feb. 15, 2021 (GLOBE NEWSWIRE) —

  • Further strengthens Centrient Pharmaceuticals’ position as the global business-to-business industry leader in beta-lactam antibiotics
  • Broadens Centrient Pharmaceuticals’ product portfolio with sterile injectable Semi-Synthetic Cephalosporin and Semi-Synthetic Penicillin finished dosage forms, able to further meet the needs of customers in these segments and become a preferred partner for customers
  • Brings in-house manufacturing capabilities for high-quality sterile antibiotic powder injectable finished dosage forms with two US FDA-approved production lines

Centrient Pharmaceuticals (“Centrient”), the business-to-business leader in sustainable, enzymatic antibiotics, next-generation statins and anti-fungals, today announced the signing of an agreement for the acquisition of Astral SteriTech Private Limited (“Astral SteriTech”), a leading international manufacturer specialised in sterile antibiotic injectable finished dosage forms. With the acquisition of Astral SteriTech, Centrient strengthens its position as the global business-to-business industry leader in beta-lactam antibiotics.

The acquisition of Astral SteriTech is an important step on Centrient’s journey to become the leading, diversified and fully integrated partner to generics marketers.

The products offered by Astral SteriTech are sterile injectable finished dosage forms for Semi-Synthetic Cephalosporins and Semi-Synthetic Penicillins. Being close to Centrient’s core products of beta-lactam antibiotics, the acquired product portfolio provides Centrient a diversification opportunity within the attractive growing niche segment of sterile injectable antibiotics.

With the broadened product portfolio, Centrient can further meet the needs of its customers in Semi-Synthetic Cephalosporin and Semi-Synthetic Penicillin finished dosage forms and become the preferred partner in these segments.

Astral SteriTech has a US FDA-approved manufacturing site with two manufacturing lines and serves customers in highly regulated markets like the United States and other regions such as South Asia.

The transaction is subject to customary regulatory approvals and closing conditions.

Rex Clements, CEO at Centrient said: The acquisition of Astral SteriTech is a significant step forward on the journey we at Centrient have undertaken to become the preferred commercial partner to our customers in Semi-Synthetic Cephalosporin and Semi-Synthetic Penicillin antibiotics.

By broadening of our product portfolio and adding advanced manufacturing capabilities, we will strengthen the delivery of our value proposition of Quality, Reliability and Sustainability.

These finished dosage forms are critical medicines in healthcare but face increasing risks of supply shortage. At Centrient, we are committed to ensuring a sustainable supply of these products in healthcare, in line with our purpose to improve lives by being at the centre of sustainable and accessible healthcare.”

Dr. Dushyant Patel, Chairman and Managing Director at Astral SteriTech said: “We are proud that with Astral SteriTech’s core competencies and proven strong track record in sterile injectable Semi-Synthetic Cephalosporin and Semi-Synthetic Penicillin finished dosage forms, we can contribute to synergize and consolidate Centrient’s antibiotics product portfolio, to support their geographical expansion agenda.

Centrient’s vision and strategies for global success blended with Astral SteriTech’s strong fundamentals in the niche area will not only enhance quality of service to existing clients but will help expand the business horizon.”

For the transaction, Barclays acted as the exclusive financial advisor, and Sidley Austin LLP and Trilegal as legal advisors to Centrient Pharmaceuticals. J.P. Morgan acted as the exclusive financial advisor and Shardul Amarchand Mangaldas & Co as legal advisor to Astral SteriTech.

———————————————————————————————————————————–

About Astral SteriTech Private Limited

Astral SteriTech is a leading international contract manufacturer specialized in sterile antibiotic powder injectable finished dosage forms.

Established as Astral Pharmaceutical Industries in 1991 by Dr. Dushyant Patel, current Chairman and Managing Director, and renamed into Astral SteriTech Private Limited in 2012, the company carved its niche as a preferred Contract and Development Manufacturing Organisation in the industry segment of sterile antibiotic injectable formulations. The company has a US FDA-approved manufacturing site with two dedicated manufacturing lines, located in Vadodara, Gujarat, India, and serves customers in high regulated markets like the United States and other regions such as South Asia.

The company’s core competencies include advanced aseptic fill and finish technologies and processes, the highest quality standards supported by its robust Quality System, regulatory services along all product development stages, and extensive product development knowledge.

For more information on Astral SteriTech please visit www.astralsteritech.com.

About Centrient Pharmaceuticals

Centrient Pharmaceuticals is the global leader in the production and commercialisation of sustainable antibiotics, next-generation statins and anti-fungals. We produce and sell intermediates, active pharmaceutical ingredients and finished dosage forms.

We stand proudly at the centre of modern healthcare, as a maker of essential and life-saving medicines. With our commitment to Quality, Reliability and Sustainability at the heart of everything we do, our over 2200 employees work continuously to meet our customers’ needs. We work towards a sustainable future by actively participating in the fight against antimicrobial resistance.

Founded 150 years ago as the ‘Nederlandsche Gist- en Spiritusfabriek’, our company was known as Gist Brocades and more recently DSM Sinochem Pharmaceuticals. Headquartered in Rotterdam (Netherlands), we have production facilities and sales offices in China, India, the Netherlands, Spain, Egypt, the United States and Mexico. Centrient Pharmaceuticals is wholly owned by Bain Capital Private Equity, a leading global private investment firm.

For more information please visit www.centrient.com or contact Centrient Pharmaceuticals Corporate Communications, Alice Beijersbergen, Director Branding & Communications. E-Mail: alice.beijersbergen@centrient.com.
Forward-looking statements

This press release may contain forward-looking statements with respect to Centrient Pharmaceuticals’ future financial

performance and position. Such statements are based on current expectations, estimates and projections of Centrient and information currently available to the company. Centrient cautions readers that such statements involve certain risks and uncertainties that are difficult to predict and therefore it should be understood that many factors can cause actual performance and position to differ materially from these statements. Centrient has no obligation to update the statements contained in this press release, unless required by law. The English language version of the press release is governing.

Alice Beijersbergen
Centrient Pharmaceuticals
+31 (6) 823 579 56
alice.beijersbergen@centrient.com

 

Civil Society Voices Key to Yemenis’ Push for Peace, Open Society Report Shows

New York, Feb. 11, 2021 (GLOBE NEWSWIRE) — Yemeni civil society organizations believe justice and accountability can play a decisive role in establishing a lasting peace in Yemen, according to a new Open Society Foundations report.

A Passage to Justice: Selected Yemeni Civil Society Views of Transitional Justice and Long-Term Accountability in Yemen highlights the leading role of Yemeni civil society in articulating the interplay between peace and justice, as well as the role that justice matters play in the peace process. It focuses on Yemenis’ views about accountability for violations committed in the war-torn country since conflict broke out there in 2014.

“Transitional justice is a transit from something to something. I believe transitional justice can help with transiting from wartime to peacetime, from destruction to construction,” the report quotes one civil society advocate from Mareb as saying. (Individuals quoted in the report are not identified by name to protect their safety.)

The Biden administration announced last week that it would end support to the Saudi-led war in Yemen. The announcement comes on the heels of other administration action aimed at bringing peace to Yemen, including an announcement to stop sales of precision-guided bombs to the Saudis, and U.S. designation of a special envoy to help negotiate a peace settlement in the war-torn country. But while these measures are welcome, the United States and the international community must also help ensure accountability and back Yemeni civil society’s efforts to disrupt the cycle of impunity that threatens to undercut any peace agreement.

“As part of its new push to the end the war, the U.S. must also back Yemeni civil society’s efforts to ensure real accountability for the crimes committed, and for the lives destroyed,” said Chris Rogers, a senior program officer at the Open Society Human Rights Initiative and an editor of the report. “Because for many Yemenis, it is not U.S. bombs that are the real enemy to lasting peace—it’s impunity.”

Many civil society leaders interviewed for the report noted that the peace process must be attuned to the concerns and needs of victims of the conflict, now entering its seventh year. “Listening to victims makes us think about peace,” one civil society leader from Aden told the report writers.

A peace plan that is sensitive to addressing the needs of victims and their families must consider the social and economic costs of the conflict, in addition to gross human rights abuses and violations. Victims’ organizations, family associations, and other civil society organizations must have a way to have their voices included in peace negotiations.

The report also shows that language on accountability and on transitional justice has progressively been de-emphasized in Security Council resolutions and other key instruments since the conflict started in 2014. The report argues for a return of stronger language to Council resolutions. It highlights the important role such language can play in building political support and, at a later stage, the endorsement of an accountability and transitional justice agenda for Yemen.

A Passage to Justice is available for download in English and in Arabic.

The Open Society Foundations, founded by George Soros, are the world’s largest private funder of independent groups working for justice, democratic governance, and human rights. We provide thousands of grants every year through a network of national and regional foundations and offices, funding a vast array of projects—many of them now shaped by the challenges of the COVID-19 pandemic.

Office of Communications
Open Society Foundations 
(212) 548-0378
media@opensocietyfoundations.org

Madison Realty Capital Completes More Than $1.5 Billion in Transactions in 2020

New York, Feb. 11, 2021 (GLOBE NEWSWIRE) — Madison Realty Capital, a fully integrated real estate private equity firm focused on debt and equity investment strategies, today announced it originated more than $1.5 billion in financing, originations and performing and non-performing note purchases in 2020, ranging from $4.9 million to $173 million. The firm closed a total of 23 transactions in major U.S. metropolitan and suburban markets across a variety of real estate asset classes including, multifamily, mixed-use, medical office, office, industrial, condo, hotel, and retail.  More than 70% of the total dollar volume was executed with repeat borrowers, reflecting the firm’s strong relationships and flexible, customer-centric investment approach. With $5.6 billion of gross assets under management, Madison Realty Capital also continued to expand its platform by launching a new income-oriented $1 billion debt investment vehicle, targeting lighter value-add and core-plus real estate transactions with rates of 4% to 7%.

“Madison Realty Capital delivered a very active 2020, executing over $1.5 billion worth of transactions for our institutional clientele, maintaining low levels of leverage, and expanding our world-class lending platform amid a highly challenging operating environment due to COVID-19,” said Josh Zegen, Managing Principal and Co-Founder of Madison Realty Capital. “For more than 16 years, Madison Realty Capital has distinguished itself by providing certainty of execution, strong underwriting capabilities, as well as flexible, efficient and creative financing solutions across market cycles. In 2020, we continued to advance our position as the partner of choice for leading institutional sponsors and top-tier independent developers and I am excited to build on our strong momentum in 2021.”

The firm pursues debt investments by originating senior secured loans and mezzanine loans ranging from $5-$500 million and preferred equity investments for the construction, acquisition and refinancing of commercial real estate.

Madison Realty Capital remained an active lender throughout 2020, amidst the COVID-19 pandemic. Notable transactions for the firm include: a $173 million construction loan to MAG Partners for a 479-unit residential rental building in the Chelsea neighborhood of Manhattan, a $170 million acquisition of a portfolio of performing and non-performing loans backed by multifamily properties in New York, New Jersey, and Los Angeles, a $165 million loan to Scape North America for the development of a 451-unit multifamily project in Boston’s Fenway neighborhood, a $150 million renovation loan to WS Communities for six multifamily redevelopments and a bridge loan for a mixed-use development site in Santa Monica and San Fernando Valley, a $102 million construction loan to Invesca Development Group to finish a 98% complete multifamily project in Pompano Beach, Florida and begin construction for a mixed-use property in Plantation, Florida, a $50 million bridge loan to refinance the Pompano Beach 214-unit luxury rental apartment, retiring its initial construction loan in November, and an $18 million loan to Houston-based medical office development firms for a six-story Class A medical office building located in The Heights neighborhood of Houston, Texas.

Madison Realty Capital brings its comprehensive experience as an owner and developer to its lending business and uses its expertise as a lender to enhance its ownership and development strategies, creating a symbiotic relationship across the business. The firm is a valued partner to both institutional sponsors and leading independent developers, known for speed, flexibility, and certainty of execution in complex situations.

About Madison Realty Capital

Madison Realty Capital is a New York City based real estate private equity firm focused on debt and equity investment strategies with regional offices in key markets including Los Angeles and Dallas. Founded in 2004, MRC has closed on approximately $13 billion of transactions in the multifamily, retail, office, industrial and hotel sectors nationwide. The firm manages investments in the United States on behalf of a global investor base. MRC is a fully integrated firm with over 60 employees across all real estate investment, development, and property management disciplines. Among other industry recognitions, MRC has been named to the Commercial Observer’s prestigious “Power 100” list of New York City real estate players and is consistently cited as one of the industry’s top construction lenders. To learn more, follow us on LinkedIn and visit www.madisonrealtycapital.com.

Nathaniel Garnick/Grace Cartwright
Madison Realty Capital
(212) 257-4170
madisonrealty@gasthalter.com